Focus on Antithrombotic Treatment of Patients under Oral Anticoagulation in need of PCI – From Randomized Clinical Trials to the Individual Patient
WebcastOVERVIEW
Focus on Antithrombotic Treatment of Patients under Oral Anticoagulation in need of PCI – From Randomized Clinical Trials to the Individual Patient is organized by European Association of Percutaneous Cardiovascular Interventions (EAPCI) and would be held on Sep 08, 2017.
An application has been made to the EACCME® for CME accreditation of this event. Learning objectives:
• Do we need a certain stent type to implant in patients in need of triple therapy
• Is the dual or triple therapy the best approach in these patients
• Can potent P2Y12 receptor inhibitors be safely combined with NOACs
• Are differences in performance of combined antiplatelet/NOAC and combined antiplatelet/vitamin K-antagonists
Additional details will be posted as soon as they are available.
An application has been made to the EACCME® for CME accreditation of this event. Learning objectives:
• Do we need a certain stent type to implant in patients in need of triple therapy
• Is the dual or triple therapy the best approach in these patients
• Can potent P2Y12 receptor inhibitors be safely combined with NOACs
• Are differences in performance of combined antiplatelet/NOAC and combined antiplatelet/vitamin K-antagonists
Additional details will be posted as soon as they are available.
SPECIALITIES
CardiologyRELATED ONLINE COURSES
Quick Links